Pediatric Rheumatology Symposium 2023

March 29-April 1, 2023. New Orleans, LA.

View by Number View by Title View Sessions

View by Date

Abstract Number: 106

Caregivers’ Perspectives on Barriers to Care in Juvenile Localized and Systemic Scleroderma
Abstract Number: 107

Validation of Serious Adverse Event Reporting in a Multicenter Registry
Abstract Number: 108

Development of Mental Health Guidance Statements for Pediatric Rheumatology
Abstract Number: 109

Long-term Safety of Biologics versus Conventional Synthetic Treatments in Systemic Juvenile Idiopathic Arthritis Patients
Abstract Number: 110

Medications Affect Antibody Responses to COVID-19 Vaccinations in Children with Autoimmune Diseases
Abstract Number: 111

Monitoring for Hypogammaglobulinemia After B-Cell Therapy in an Academic Pediatric Center
Abstract Number: 112

Adverse Childhood Experiences: Prevalence and Relationship to Disease in Childhood-onset Lupus
Abstract Number: 113

Proportion of Patients with a Polyphasic Disease Course in Systemic-onset Juvenile Idiopathic Arthritis May Be Higher in the Age of Cytokine Inhibitors
Abstract Number: 114

Clinical Significance of SSA and SSB Antibodies in Pediatric SLE Patients: A Single Center Cohort
Abstract Number: 115

Development of an Electronic Clinical Phenotype to Identify Potential Study Subjects with Juvenile Arthritis
Abstract Number: 116

Clinical Significance of Anti-Scl-70 Antibodies in Pediatric Lupus Patients: A Single Center Cohort
Abstract Number: 117

A Descriptive Study of Patients with Multisystem Inflammatory Syndrome in Children
Abstract Number: 118

Serum Hepatocyte Growth Factor in Children with Juvenile Idiopathic Arthritis
Abstract Number: 119

Laser Flare Photometery in the Pediatric Rheumatology Clinic as a Screening Tool for Juvenile Idiopathic Arthritis Associated Uveitis
Abstract Number: 120

The Brazilian Registry of Juvenile Dermatomyositis (JDM): I- Onset Clinical Features and Disease Activity Scores by DAS-20 over 2-Years-Follow Up